Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Florida divided over genetically modified mosquitoes
Voters in Florida are divided on whether or not to use genetically modified mosquitoes in the fight against Zika and other viruses.
Referendum reveals concerns over planned release

Voters in Florida are divided on whether or not to use genetically modified mosquitoes in the fight against Zika and other viruses, according to the Centre for Infectious Disease Research and Policy.

The Centre say that, in a non-binding referendum, 58 per cent of voters in Monroe County voted in favour of using the mosquitoes. Meanwhile in Key Haven - a neighbourhood where the insects would be released next spring - 65 per cent of voters opposed the idea.

In spite of the need for mosquito control, locals worry that genetically modified mosquitoes may pose an unpredicted environmental threat. It is thought that early reports, which erroneously linked microcephaly to genetically modified mosquitoes, may also have a part to play in the doubt.

The genetically modified mosquitoes are manufactured by British company Oxitec, who plan to assess their effectiveness for fighting Zika.  According to BBC News, Oxitec want to release male insects across a 17-hectare region of Key Haven, a small suburb located on an island on Florida’s southern tip.

The US Food & Drug administration approved Oxitec’s mosquitoes for use in August, saying that, following months of comments from the public, the mosquitos fell under the category of Finding of No Significant Impact (FONSI).

The results of the Florida poll will now be put to board members on 19 November, who will make the final decision on whether the mosquitoes will be used next spring.

Speaking to BBC News, Dr Derric Nimmo, who has been leading Oxitec’s proposed trial in Key Haven, said: We've had six years of releases, involving millions of male mosquitoes, and there have been no reports of any adverse effects."

"It's important we're as transparent as possible... we've been trying to give people the facts and information so they can make an informed choice."

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.